Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films

International Journal of Pharmaceutics

Volumn 256, Issue 1-2, 2003, Pages 43-52

  Kramar, A ^a   Turk, S ^a   Vrecer F ^a  

^a KRKA D D   (Slovenia)

Author keywords

Box Behnken design; Diclofenac sodium; Dissolution; Eudragit RL; Eudragit RS; Pellet coating; Sustained release

Indexed keywords

CITRIC ACID TRIETHYL ESTER; DICLOFENAC; PLASTICIZER; POLYMETHACRYLIC ACID;

APPARATUS; AQUEOUS SOLUTION; COMPUTER; CONFERENCE PAPER; DISPERSION; DRUG COATING; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; EXPERIMENTAL DESIGN; FILM COATING; PARAMETER; PARTICULATE MATTER; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURFACE PROPERTY; SUSTAINED RELEASE PREPARATION; THERMOSTABILITY;

EID: 0037473471     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00061-9     Document Type: Conference Paper

References (18)

1. ® RS30 D film-coated sustained-release theophylline pellets. Eur. J. Pharm. Biopharm. 1:1996;29-35.
2. Bodea A., Leucuta S.E. Optimisation of propranolol hydrochloride sustained-release pellets using Box-Behnken design and desirability function. Drug Dev. Ind. Pharm. 24:1998;145-155.
3. Daumesnil, R., 1994. Multiparticulate Oral Drug Delivery. Marcel Dekker, New York, pp. 457-474.
4. Follonier N., Doelker E. Biopharmaceutical comparison of oral multiple-unit and single unit sustained release dosage forms. STP Pharm. Sci. 2:1992;141-158.
5. Gutierrez-Roca J.C., McGinity J.W. Influence of water soluble and insoluble plasticizers on the physical and mechanical properties of acrylic resin copolymers. Int. J. Pharm. 103:1994;293-301.
6. Harris, M.R., Ghebre-Sellassie, I., 1997. Aqueous polymeric coating for modified release oral dosage forms. In: McGinity, J.W. (Ed.), Aqueous Polymeric Coating for Pharmaceutical Dosage Forms. Marcel Dekker, New York, pp. 81-101.
7. Karnachi A.A., Khan M.A. Box-Behnken design for the optimisation of formulation variables of indomethacin coprecipitates with polymer mixtures. Int. J. Pharm. 131:1996;9-17.
8. ® S100 coprecipitates to obtain controlled release tablets. Drug Dev. Ind. Pharm. 22:1996;135-141.
9. Lehmann, K., 1989. Coating of multiparticulates using polymeric solution. In: Ghebre-Sellassie, I. (Ed.), Pharmaceutical Pelletization Tehnology. Marcel Dekker, New York, pp. 51-77.
10. Lehmann, K., Aβmus, M., Bössler, H., et al., 1996. Practical course in film coating of pharmaceutical dosage forms with Eudragit, Information brochure, Röhm GmbH, Darmstadt, pp. 1-12.
11. Lippold B.C., Gunder W., Lippold B.H. Drug release from diffusion pellets coated with the aqueous ethyl cellulose dispersion aquacoat ECD-30 and 20% dibutyl sebacate as plasticizer: partion mechanism and pore diffusion. Eur. J. Pharm. Biopharm. 47:1999;27-32.
12. Mutscher, E., Derendorf, H., 1995. Drug Action: Basic Principles and Therapeutic Aspects. Medpharm Scientific Publishers, Stuttgart, pp. 165-171.
13. Oh E., Luner P.E. Surface free energy of ethylcellulose film and influence of plasticizers. Int. J. Pharm. 188:1999;203-219.
14. Petereit H.U., Weisbrod W. Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers. Eur. J. Pharm. Biopharm. 47:1999;15-25.
15. Schwartz, J.B., O'Connor, R.E., 1997. Optimization techniques in pharmaceutical formulation and processing. In: Banker, G.S., Rhodes, C.T. (Eds.), Modern Pharmaceutics, 3rd ed. Marcel Dekker, New York, pp. 727-752.
16. Singh S.K., Dodge J., Durrani J.M. Optimisation and characterization of controlled release pellets coated with an experimental latex. Int. J. Pharm. 125:1995;243-255.
17. ® RS 30 D. Int. J. Pharm. 152:1997;153-163.
18. Wesseling M., Bodmeier R. Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, Aquacoat, or an organic ethylcellulose solution. Eur. J. Pharm. Biopharm. 47:1999;33-38.